Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

287 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antisense oligonucleotides: promise and reality.
Lebedeva I, Stein CA. Lebedeva I, et al. Annu Rev Pharmacol Toxicol. 2001;41:403-19. doi: 10.1146/annurev.pharmtox.41.1.403. Annu Rev Pharmacol Toxicol. 2001. PMID: 11264463 Review.
Cellular delivery of antisense oligonucleotides.
Lebedeva I, Benimetskaya L, Stein CA, Vilenchik M. Lebedeva I, et al. Eur J Pharm Biopharm. 2000 Jul;50(1):101-19. doi: 10.1016/s0939-6411(00)00088-6. Eur J Pharm Biopharm. 2000. PMID: 10840195 Review.
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
Lebedeva IV, Emdad L, Su ZZ, Gupta P, Sauane M, Sarkar D, Staudt MR, Liu SJ, Taher MM, Xiao R, Barral P, Lee SG, Wang D, Vozhilla N, Park ES, Chatman L, Boukerche H, Ramesh R, Inoue S, Chada S, Li R, De Pass AL, Mahasreshti PJ, Dmitriev IP, Curiel DT, Yacoub A, Grant S, Dent P, Senzer N, Nemunaitis JJ, Fisher PB. Lebedeva IV, et al. Int J Oncol. 2007 Nov;31(5):985-1007. Int J Oncol. 2007. PMID: 17912425 Review.
287 results